Cargando…

Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics

ABSTRACT: Fungi produce several bioactive metabolites, pigments, dyes, antioxidants, polysaccharides, and industrial enzymes. Fungal products are also the primary sources of functional food and nutrition, and their pharmacological products are used for healthy aging. Their molecular properties are v...

Descripción completa

Detalles Bibliográficos
Autores principales: Shankar, Akshay, Sharma, Krishna Kant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095418/
https://www.ncbi.nlm.nih.gov/pubmed/35546367
http://dx.doi.org/10.1007/s00253-022-11945-8
_version_ 1784705747243761664
author Shankar, Akshay
Sharma, Krishna Kant
author_facet Shankar, Akshay
Sharma, Krishna Kant
author_sort Shankar, Akshay
collection PubMed
description ABSTRACT: Fungi produce several bioactive metabolites, pigments, dyes, antioxidants, polysaccharides, and industrial enzymes. Fungal products are also the primary sources of functional food and nutrition, and their pharmacological products are used for healthy aging. Their molecular properties are validated through the use of recent high-throughput genomic, transcriptomic, and metabolomic tools and techniques. Together, these updated multi-omic tools have been used to study fungal metabolites structure and their mode of action on biological and cellular processes. Diverse groups of fungi produce different proteins and secondary metabolites, which possess tremendous biotechnological and pharmaceutical applications. Furthermore, its use and acceptability can be accelerated by adopting multi-omics, bioinformatics, and machine learning tools that generate a huge amount of molecular data. The integration of artificial intelligence and machine learning tools in the era of omics and big data has opened up a new outlook in both basic and applied researches in the area of nutraceuticals and functional food and nutrition. KEY POINTS: • Multi-omic tool helps in the identification of novel fungal metabolites • Intra-omic data from genomics to bioinformatics • Novel metabolites and application in human health
format Online
Article
Text
id pubmed-9095418
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90954182022-05-12 Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics Shankar, Akshay Sharma, Krishna Kant Appl Microbiol Biotechnol Mini-Review ABSTRACT: Fungi produce several bioactive metabolites, pigments, dyes, antioxidants, polysaccharides, and industrial enzymes. Fungal products are also the primary sources of functional food and nutrition, and their pharmacological products are used for healthy aging. Their molecular properties are validated through the use of recent high-throughput genomic, transcriptomic, and metabolomic tools and techniques. Together, these updated multi-omic tools have been used to study fungal metabolites structure and their mode of action on biological and cellular processes. Diverse groups of fungi produce different proteins and secondary metabolites, which possess tremendous biotechnological and pharmaceutical applications. Furthermore, its use and acceptability can be accelerated by adopting multi-omics, bioinformatics, and machine learning tools that generate a huge amount of molecular data. The integration of artificial intelligence and machine learning tools in the era of omics and big data has opened up a new outlook in both basic and applied researches in the area of nutraceuticals and functional food and nutrition. KEY POINTS: • Multi-omic tool helps in the identification of novel fungal metabolites • Intra-omic data from genomics to bioinformatics • Novel metabolites and application in human health Springer Berlin Heidelberg 2022-05-12 2022 /pmc/articles/PMC9095418/ /pubmed/35546367 http://dx.doi.org/10.1007/s00253-022-11945-8 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Mini-Review
Shankar, Akshay
Sharma, Krishna Kant
Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
title Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
title_full Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
title_fullStr Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
title_full_unstemmed Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
title_short Fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
title_sort fungal secondary metabolites in food and pharmaceuticals in the era of multi-omics
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095418/
https://www.ncbi.nlm.nih.gov/pubmed/35546367
http://dx.doi.org/10.1007/s00253-022-11945-8
work_keys_str_mv AT shankarakshay fungalsecondarymetabolitesinfoodandpharmaceuticalsintheeraofmultiomics
AT sharmakrishnakant fungalsecondarymetabolitesinfoodandpharmaceuticalsintheeraofmultiomics